All Comments by
- Richard C. Mohs on Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.
- Chris Exley on Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.
- Lary Walker on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
- Michael Greicius on Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
- Martin Farlow on Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
- David Knopman on Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
- Veronique Dorval on Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.
- Christopher Nowinski on Brief: NFL Survey on Dementia Splashes Across Front Pages
- Ann McKee on Brief: NFL Survey on Dementia Splashes Across Front Pages
- Masood Kamali-Moghaddam on Stayin’ Alive—Huge Study Quickens Quest for Plasma AD Biomarker
- Iliya Lefterov on Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.
- Markus Britschgi on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
- Harry LeVine III on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
- James Bergey on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
- Philip Scheltens on The prevalence of cortical gray matter atrophy may be overestimated in the healthy aging brain.